Matches in Wikidata for { <http://www.wikidata.org/entity/Q64657361> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q64657361 description "clinical trial" @default.
- Q64657361 description "ensayu clínicu" @default.
- Q64657361 description "klinisch onderzoek" @default.
- Q64657361 description "клінічне випробування" @default.
- Q64657361 name "Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis" @default.
- Q64657361 type Item @default.
- Q64657361 label "Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis" @default.
- Q64657361 prefLabel "Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis" @default.
- Q64657361 P1050 Q64657361-100C58EC-FB49-4D04-BBB3-CBB7E2A73D08 @default.
- Q64657361 P1050 Q64657361-CB5725D5-7838-4C43-A88D-41BA93F83345 @default.
- Q64657361 P1132 Q64657361-A53BDF19-3AFE-4B1C-90CE-18A38AD8977B @default.
- Q64657361 P1476 Q64657361-4E3B56A0-675B-4D14-B76E-9DF4C6A73F17 @default.
- Q64657361 P17 Q64657361-28746A4D-85CE-464A-A69F-9BDB04503C46 @default.
- Q64657361 P17 Q64657361-366D257C-6E35-4923-B5C7-4371A21D0327 @default.
- Q64657361 P17 Q64657361-4211FFDA-67A7-47A7-B2FD-22069EA70B75 @default.
- Q64657361 P17 Q64657361-5FF746CC-2935-4D0C-B1E9-BDBAE2F12805 @default.
- Q64657361 P17 Q64657361-9F27FC7F-F0C5-4DAD-B517-41415A5A7D87 @default.
- Q64657361 P17 Q64657361-C0860251-C794-482B-B27D-916DA9907EF3 @default.
- Q64657361 P1813 Q64657361-6331B221-D7C6-4BCF-8206-A48CB494B80E @default.
- Q64657361 P2899 Q64657361-C931EFA5-7067-4ED5-826A-4F87C2310BF7 @default.
- Q64657361 P3098 Q64657361-8C4C12BC-FD89-4F93-933B-C28CD5A448BA @default.
- Q64657361 P31 Q64657361-FADF24F7-EF12-42F3-8E2F-B39AFFFEF3B4 @default.
- Q64657361 P4135 Q64657361-5D67DC01-1E4E-4002-98D7-43745840B4A5 @default.
- Q64657361 P580 Q64657361-BB6ED103-4201-4938-B886-C873E93C433A @default.
- Q64657361 P582 Q64657361-8EACDE3F-533F-4448-887D-7392BB611C38 @default.
- Q64657361 P6099 Q64657361-E1DB994F-0DDF-4A59-BC23-161E92ADDA59 @default.
- Q64657361 P8363 Q64657361-36249308-993D-45E9-A7C7-3011D62D1679 @default.
- Q64657361 P1050 Q140067 @default.
- Q64657361 P1050 Q8277 @default.
- Q64657361 P1132 "+410" @default.
- Q64657361 P1476 "A Multicenter, Open-label, Extension Study to Evaluate the Long Term Safety and Efficacy of Daclizumab High Yield Process (DAC HYP) Monotherapy in Subjects With Multiple Sclerosis Who Have Completed Treatment in Study 205MS202 (SELECTION)" @default.
- Q64657361 P17 Q145 @default.
- Q64657361 P17 Q183 @default.
- Q64657361 P17 Q212 @default.
- Q64657361 P17 Q28 @default.
- Q64657361 P17 Q36 @default.
- Q64657361 P17 Q668 @default.
- Q64657361 P1813 "SELECTED" @default.
- Q64657361 P2899 "+18" @default.
- Q64657361 P3098 "NCT01051349" @default.
- Q64657361 P31 Q30612 @default.
- Q64657361 P4135 "+60" @default.
- Q64657361 P580 "2010-03-31T00:00:00Z" @default.
- Q64657361 P582 "2016-08-25T00:00:00Z" @default.
- Q64657361 P6099 Q42824440 @default.
- Q64657361 P8363 Q78089383 @default.